Multiple Assemblies exist for SMTL entry 6to7
Crystal structure of the Orexin-1 receptor in complex with suvorexant at 2.29 A resolution; X-RAY DIFFRACTION 2.26 Å

SMTL ID
6to7.1
Ligands
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone; TETRAETHYLENE GLYCOL; CITRIC ACID; 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL; (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate; SODIUM ION
Polypeptides
Orexin receptor type 1
Oligo-state
monomer
SMTL ID
6to7.2
Ligands
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone; TETRAETHYLENE GLYCOL; 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL; (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate; SODIUM ION
Polypeptides
Orexin receptor type 1
Oligo-state
monomer